SHANGHAI ALLIST PHARMACEUTICALS CO revenue breakdown overview

SHANGHAI ALLIST PHARMACEUTICALS CO revenue for the last year amounted to 3.56 B CNY, the most of which — 3.51 B CNY — came from its highest performing source at the moment, Anti-tumor, the year earlier bringing 1.98 B CNY. The greatest contribution to the revenue figure was made by China — last year it brought SHANGHAI ALLIST PHARMACEUTICALS CO 3.56 B CNY, and the year before that — 1.98 B CNY.